APIChina provides an integrated platform with small molecule APIs/intermediates development and manufacturing capabilities from preclinical to commercial stages.
We are striving to offer a wide range of services including synthetic route development, process development and optimization, scale up, registration and validation batch manufacture, and commercial supply production. Our state-of-the-art Pharmaceutical manufacturing facilities are capable of producing APIs and advanced intermediates from grams to kilogram quantities.
As a research-driven and customer-based company, APIChina is committed to help our worldwide clients shorten the time and lower the cost of drug development and manufacturing. We enable customers to benefit from our tailored methods that balance their needs in terms of speed and cost.